RETNLB Polyclonal antibody

RETNLB Polyclonal Antibody for IHC, ELISA
Cat No. 18232-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IHC, ELISA

CCRG, FIZZ1, FIZZ2, HXCP2, RELM beta, RELMb, RELMbeta, resistin like beta, RETNL2, RETNLB, XCP2

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive IHC detected inhuman small intestine tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

推荐稀释比

应用推荐稀释比
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

18232-1-AP targets RETNLB in IHC, ELISA applications and shows reactivity with human samples.

经测试应用 IHC, ELISA Application Description
经测试反应性 human
免疫原 RETNLB fusion protein Ag12912 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 resistin like beta
别名 CCRG, FIZZ1, FIZZ2, HXCP2, RELM beta, RELMb, RELMbeta, resistin like beta, RETNL2, RETNLB, XCP2
计算分子量 111 aa, 12 kDa
GenBank蛋白编号BC069318
基因名称 RETNLB
Gene ID (NCBI) 84666
RRIDAB_2935447
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ9BQ08
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

RETNLB is an intestinal goblet cell-specific protein and is notably upregulated during intestinal inflammation. RETNLB also plays a role in several research areas, such as inflammatory disease, cancer, and metabolic function. In tumors, previous reports have suggested that positive expression of RETNLB was detected in most tissues from gastric carcinoma and colon cancer patients, RETNLB was also found involvement in oral squamous cell carcinoma [PMID: 34158059 19706296 27001185 15983036].

实验方案

Product Specific Protocols
IHC protocol for RETNLB antibody 18232-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...